| Serial Number | 87093137 |
| Word Mark | OXITRAN |
| Filing Date | Tuesday, July 5, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, January 26, 2024 |
| Registration Number | 5239739 |
| Registration Date | Tuesday, July 11, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 7, 2017 |
| Goods and Services | Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use in connection with the aforementioned diseases |
| Goods and Services | Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries |
| Goods and Services | Medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; genetic animal model testing and scientific research for neuro-muscular and ophthalmological diseases for research purposes |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Santhera Pharmaceuticals (Schweiz) AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Pratteln CH-4133 CH |
| Party Name | Santhera Pharmaceuticals (Schweiz) AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Liestal 4410 CH |
| Party Name | Santhera Pharmaceuticals (Schweiz) AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Liestal 4410 CH |
| Event Date | Event Description |
| Friday, January 26, 2024 | CANCELLED SEC. 8 (6-YR) |
| Monday, July 11, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, June 20, 2018 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, June 20, 2018 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 11, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Friday, June 2, 2017 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Thursday, May 11, 2017 | NOTICE OF ALLOWANCE CANCELLED |
| Friday, June 2, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, May 11, 2017 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, May 2, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 7, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 7, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 15, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 31, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, January 25, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 24, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 24, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 17, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 29, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 29, 2016 | NON-FINAL ACTION E-MAILED |
| Thursday, December 29, 2016 | NON-FINAL ACTION WRITTEN |
| Thursday, December 29, 2016 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, December 23, 2016 | ASSIGNED TO LIE |
| Thursday, November 17, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 17, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 17, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 1, 2016 | ASSIGNED TO LIE |
| Wednesday, October 26, 2016 | ASSIGNED TO LIE |
| Tuesday, October 18, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 18, 2016 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, October 18, 2016 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, October 18, 2016 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, October 18, 2016 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Thursday, October 13, 2016 | ASSIGNED TO EXAMINER |
| Friday, July 8, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 8, 2016 | NEW APPLICATION ENTERED |